CPSF1
protein-codingcleavage and polyadenylation specific factor 1, the group of Cleavage and polyadenylation specific factor subunits|MicroRNA protein coding host genes
Gene summary
Cleavage and polyadenylation specificity factor (CPSF) is a multisubunit complex that plays a central role in 3-prime processing of pre-mRNAs. CPSF recognizes the AAUAAA signal in the pre-mRNA and interacts with other proteins to facilitate both RNA cleavage and poly(A) synthesis. CPSF1 is the largest subunit of the CPSF complex (Murthy and Manley, 1995 [PubMed 7590244]).[supplied by OMIM, Mar 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~16.1 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0032941
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Ophthalmologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CPSF1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_013291.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 37 | 1 | 44 | ||
| missense | 1 | 239 | 5 | 245 | ||
| nonsense | 1 | 2 | 3 | |||
| start loss | 0 | |||||
| frameshift | 2 | 3 | 2 | 2 | 9 | |
| splice donor/acceptor (+/-2bp) | 1 | 1 | 21 | 23 | ||
| Total | 5 | 4 | 270 | 44 | 1 | 324 |
Highest pathogenic variant AF is 0.00008061356
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_037423.2 | 37 | MANE Select | |
| Ensembl | ENSP00000484669.1 | 37 | MANE Select | |
| Ensembl | ENSP00000435761.2 | 5 | Standard | |
| Ensembl | ENSP00000483775.1 | 6 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| cpsf1 | Danio rerio | Structure: hematopoietic stem cell Quality: decreased amount abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- mRNA surveillance pathway - Homo sapiens (human)
- mRNA Processing
- tRNA processing
- Gene expression (Transcription)
- polyadenylation of mrna
Biological Process
- mRNA splicing, via spliceosome
- termination of RNA polymerase II transcription
- mRNA polyadenylation
- mRNA export from nucleus
- mRNA 3'-end processing
Molecular Function
- protein binding
- enzyme binding
- mRNA 3'-UTR AU-rich region binding
Cellular Component
- nucleus
- nucleoplasm
- mRNA cleavage and polyadenylation specificity factor complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000349769
- Coding exons
- 37
- Length
- 16310
- Individuals with no LoFs
- 125565
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 172
- Defined
- 125737
- p
- 0.000684
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.80 | 719 | 964 | 0.746 | 0.0000668 | 9325 |
| Missense (PolyPhen) | 173 | 333.37 | 0.51895 | 3253 | ||
| Synonymous | -3.05 | 508 | 428 | 1.19 | 0.0000332 | 2919 |
| Loss of Function | 4.84 | 30 | 75.3 | 0.398 | 0.00000365 | 822 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0039 | 0.0026 | notable |
| Latino/Admixed American | 0.00076 | 0.00055 | rare |
| Ashkenazi Jewish | 0.0025 | 0.0016 | notable |
| East Asian | 0.00050 | 0.00049 | rare |
| Finnish | 0.000048 | 0.000046 | rare |
| European (Non-Finnish) | 0.00081 | 0.00060 | rare |
| South Asian | 0.00043 | 0.00042 | rare |
| Other | 0.00084 | 0.00049 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Component of the cleavage and polyadenylation specificity factor (CPSF) complex that plays a key role in pre- mRNA 3'-end formation, recognizing the AAUAAA signal sequence and interacting with poly(A) polymerase and other factors to bring about cleavage and poly(A) addition. This subunit is involved in the RNA recognition step of the polyadenylation reaction. {ECO:0000269|PubMed:14749727}.;
Recessive Scores
- pRec
- 0.131
Intolerance Scores
- LoFtool
- 0.668
- RVIS EVS
- -3.4
- RVIS percentile EVS
- 0.37
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- H
- Indispensability pred.
- E
- Indispensability score
- 0.911
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |